Sign In
Buy ZTS
$74.17
-1.16 (-1.54%)
At Close: Jul 22, 2026
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
12:40pm, Friday, 12'th Sep 2025
Investors looking for stocks in the Medical - Drugs sector might want to consider either Sandoz Group AG Sponsored ADR (SDZNY) or Zoetis (ZTS). But which of these two stocks is more attractive to valu
Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
12:09pm, Friday, 12'th Sep 2025
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--If approved, Zoetis' Portela will be the first long-acting anti-NGF mAb therapy for cats and is designed to provide 3 months of OA pain relief
Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why
07:16pm, Tuesday, 09'th Sep 2025
Zoetis (ZTS) reached $149.79 at the closing of the latest trading day, reflecting a -1.29% change compared to its last close.
Zoetis Inc. (ZTS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
04:16pm, Monday, 08'th Sep 2025
Zoetis Inc. (NYSE:ZTS ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 1:05 PM EDT Company Participants Kristin Peck - CEO & Director Wetteny Joseph - Executive VP & CFO Con
Phibro Animal Health: Zoetis Growth, Valuation Still Attractive
09:15am, Tuesday, 02'nd Sep 2025
Phibro Animal Health Corporation's Zoetis MFA acquisition has revitalized its overall growth. Animal Health is now around 75% of their total sales, and its integration should be finalized by Q4 2025.
Zoetis: A Solid Dividend Growth Investment For The Long Haul
04:14am, Monday, 01'st Sep 2025
Zoetis is a global leader in animal health with strong organic growth, robust product innovation, and strategic M&A driving long-term revenue and earnings expansion. The company boasts exceptional div
SDZNY or ZTS: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 27'th Aug 2025
Investors looking for stocks in the Medical - Drugs sector might want to consider either Sandoz Group AG Sponsored ADR (SDZNY) or Zoetis (ZTS). But which of these two companies is the best option for
Zoetis: Why I Decided To Invest In The Stock
01:45am, Monday, 25'th Aug 2025
Zoetis remains the global leader in animal health, with 68% of revenue from companion animals. Q2 results showed 8% organic sales growth and 15% adjusted earnings growth. Librela sales in the U.S. dec
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
05:52am, Tuesday, 12'th Aug 2025
Right now is not a good time in the healthcare sector. Various companies across the space are well below highs while the broader stock market chugs along at all-time highs.
Zoetis Announces Pricing of $1.85 Billion of Senior Notes
06:48pm, Monday, 11'th Aug 2025
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today announced that it has agreed to sell $1.850 billion of senior notes, consisting of $850.0 million aggregate princ
If You'd Invested $1,000 in Zoetis (ZTS) Stock 10 Years Ago, Here's How Much You'd Have Today
01:56pm, Monday, 11'th Aug 2025
Ah, 10 years ago. It was 2015, and selfie sticks and hoverboards were all over.
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
12:41pm, Monday, 11'th Aug 2025
Investors with an interest in Medical - Drugs stocks have likely encountered both Sandoz Group AG Sponsored ADR (SDZNY) and Zoetis (ZTS). But which of these two companies is the best option for those
2 Stocks to Buy With $5,000 and Hold for a Decade
10:38am, Sunday, 10'th Aug 2025
It can be tempting to try to predict market movements so you buy low and sell high, but it's notoriously difficult to execute successfully. Even if you succeed once or twice, replicating that often en
Why Zoetis (ZTS) is a Top Growth Stock for the Long-Term
10:46am, Wednesday, 06'th Aug 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zoetis CEO: It's unclear if animal health will be a part of pharmaceutical tariffs
05:14pm, Tuesday, 05'th Aug 2025
Kristin Peck, Zoetis CEO, joins 'Closing Bell: Overtime' to discuss Q2 earnings, tariff impact on business and domestic production.
